A Neu View of Invasive Lobular Breast Cancer

被引：5
|
作者：
Bose, Ron [1 ,2 ]
机构：
[1] Washington Univ, Sch Med, Dept Med, Div Oncol, St Louis, MO 63110 USA
[2] Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA
来源：
CLINICAL CANCER RESEARCH | 2013年 / 19卷 / 13期
关键词：
MUTATIONS; DOMAIN; HER2; AMPLIFICATION; CARCINOMA; ERBB2;
D O I：
10.1158/1078-0432.CCR-13-1031
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Genome sequencing of relapsed, invasive lobular breast cancer identified actionable mutations in 86% of the cases. HER2 alterations occur in 27% of the cases, including 4 cases with activating HER2 mutations and 1 with a novel HER2-GRB7 gene fusion. This fusion links the HER2 tyrosine kinase domain to the GRB7 src homology 2 (SH2) domain. (C)2013 AACR.
引用
收藏
页码：3331 / 3333
页数：3
相关论文
共 50 条
  • [31] Invasive lobular cancer of the breast - Is breast conservation surgery a good option?
    Raje, Durgesh
    Bollard, Ruth
    Wilson, Alan
    BREAST JOURNAL, 2006, 12 (06): : 574 - 575
  • [32] Invasive breast cancer following ductal and lobular carcinoma in situ of the breast
    Levi, F
    Randimbison, L
    Te, VC
    La Vecchia, C
    INTERNATIONAL JOURNAL OF CANCER, 2005, 116 (05) : 820 - 823
  • [33] Imaging and invasive lobular carcinoma: A survey study conducted by the lobular breast cancer alliance
    Hutcheson, Laurie B.
    Axelrod, Janice
    Fitzwater, Colleen L.
    Jochelson, Maxine S.
    Joergensen, Gitte H.
    Langdon, Theresa
    Levine, Julia K.
    Metzger, Otto
    Mitchell-Daniels, Mason
    Neilsen, Barbara F.
    CANCER RESEARCH, 2022, 82 (04)
  • [34] Higher risk of metachronous contralateral breast cancer in patients with invasive lobular breast cancer
    Akdeniz, D.
    Kramer, I.
    Van Deurzen, C. H. M.
    Schaapveld, M.
    Westenend, P. J.
    Voogd, A. C.
    Jager, A.
    Steyerberg, E. W.
    Sleijfer, S.
    Schmidt, M. K.
    Hooning, M. J.
    EUROPEAN JOURNAL OF CANCER, 2018, 92 : S46 - S46
  • [35] Higher risk of metachronous contralateral breast cancer in patients with invasive lobular breast cancer
    Akdeniz, D.
    Kramer, I.
    van Deurzen, C. H.
    Schaapveld, M.
    Westenend, P. J.
    Voogd, A. C.
    Jager, A.
    Steyerberg, E. W.
    Sleijfer, S.
    Schmidt, M. K.
    Hooning, M. J.
    CANCER RESEARCH, 2019, 79 (04)
  • [36] Survival analysis between patients with invasive ductal and invasive lobular breast cancer
    Dian, Darius
    Herold, Hannes
    Mylonas, Ioannis
    Scholz, Christoph
    Janni, Wolfgang
    Sommer, Harald
    Friese, Klaus
    ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2009, 279 (01) : 23 - 28
  • [37] Survival analysis between patients with invasive ductal and invasive lobular breast cancer
    Darius Dian
    Hannes Herold
    Ioannis Mylonas
    Christoph Scholz
    Wolfgang Janni
    Harald Sommer
    Klaus Friese
    Archives of Gynecology and Obstetrics, 2009, 279 : 23 - 28
  • [38] RISK OF INVASIVE CANCER IN WOMEN WITH LOBULAR CARCINOMA INSITU OF THE BREAST
    SALVADORI, B
    BARTOLI, C
    ZURRIDA, S
    DELLEDONNE, V
    SQUICCIARINI, P
    ROVINI, D
    BARLETTA, L
    EUROPEAN JOURNAL OF CANCER, 1991, 27 (01) : 35 - 37
  • [39] Perforated gastric carcinomatosis following invasive lobular cancer of the breast
    De Gruttola, Ivan
    Adil, Md Tanveer
    D'Souza, Lorraine
    Jambulingam, Periyathambi
    Whitelaw, Douglas
    CLINICAL CASE REPORTS, 2019, 7 (05): : 999 - 1002
  • [40] Magnetic resonance imaging for invasive ductal or lobular breast cancer
    Kuenzell, Judith Lorenz
    GEBURTSHILFE UND FRAUENHEILKUNDE, 2023, 83 (01)
12345